Understanding Myeloma

Step One in Trial Participation: How Can Patients Learn About New Trials?

Myeloma survivor Reina Weiner and Lazarex chairman Dana Dornsife discuss ways patients can learn about new clinical trial opportunities and share resources to help alleviate the financial burden.

Published:

What Nutrition Guidelines Are Most Beneficial to Myeloma Patients?

Expert Kristen Carter gives nutrition guidelines to help multiple myeloma patients maintain a healthy diet and lifestyle during or after treatment. Watch now to find out more.

Published:

What Are the Barriers to Accessing Novel Agents in Myeloma?

What disparities exist today that prevent myeloma patients from using innovative treatments? Watch now to hear a panel of myeloma experts pinpoint the challenges people may face in accessing cancer care.

Published:

Transparency in Clinical Trials: Data, Safety and Monitoring of Cancer Patients

Many patients wonder; how safe are clinical trials? How transparent is the data from clinical research? Tune in to hear Dr. Mike Thompson and Jim Omel discuss clinical trial care and how the efficacy of new cancer treatments is determined.

Published:

Session 2 Replay : The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatment News Into Perspective

Drs. Jonathan L. Kaufman, Ajay Nooka and Rafael Fonseca, discuss the latest news on the myeloma treatment landscape and research at “The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatment News” town meeting in Atlanta.

Published:

Session 1 Replay: The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatment News Into Perspective

Drs. Jonathan Kaufman, Ajay Nooka and Rafael Fonseca, discuss the latest news on the myeloma treatment landscape and research at recent town meeting in Atlanta.

Published:

What Treatment Options Are Available for Myeloma Patients With Severe Neuropathy?

Myeloma experts Kristen Carter and Dr. Joshua Richter share suggestions for reducing the effects of severe neuropathy as a side effect from multiple myeloma treatment. Watch now to learn more.

Published:

Evaluating Inclusion and Exclusion Criteria in Clinical Trials

Eligibility criteria determines who can and cannot participate in a clinical trial. Do today’s studies reflect the actual patient population? Why is inclusion so narrow in some cases? Watch now to hear from Dr. Mike Thompson and Jim Omel.

Published:

Actionable Advice and Resources for Knocking Down Obstacles to Trial Participation

More often than not, only a small fraction of patients enroll in a trial due to barriers posed by financial logistics, distrust and travel, to name a few. How do we remove obstacles, clearing the way for patients to have more access to clinical trials? Watch now to find out.

Published:

Showing 9 of 232 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 5, 2014